Supplementary Figure 3: Mitochondrial dysfunction in Drosophila pink1 mutants is complemented by dNK. | Nature Cell Biology

Supplementary Figure 3: Mitochondrial dysfunction in Drosophila pink1 mutants is complemented by dNK.

From: Enhancing nucleotide metabolism protects against mitochondrial dysfunction and neurodegeneration in a PINK1 model of Parkinson’s disease

Supplementary Figure 3

(a) Expression of dNK partially reverses metabolic shifts in pink1 mutants. Orange and cyan correspond to metabolites that are respectively upregulated and downregulated to a significant level. The statistical significance was determined using Welch’s Two Sample t-test (n = 8). See also Supplementary Table 6. (b) dNK expression increases mtDNA levels in pink1 mutants. The ratio of mtDNA to nDNA was measured by real-time PCR in flies with the indicated genotypes (mean±SD, n = 6 per genotype, asterisks, one-way ANOVA with Bonferroni’s multiple comparison test). (c) Expression of dNK restores the levels of mitochondrial respiratory complexes in pink1 mutants. Whole-fly lysates were analysed by western blot analysis using the indicated antibodies. (d) dNK expression rescues ATP levels in pink1 mutants. Data are shown as the mean±SD (n = 6 per genotype, asterisks, one-way ANOVA with Bonferroni’s multiple comparison test). (e) dNK expression enhances respiration in pink1 mutants. Data are shown as the mean±SD (n = 3 per genotype, asterisks, two-tailed unpaired t test). See Supplementary Table 9 for statistics source data. (f) dNK expression suppresses motor impairment in pink1 mutants. Flies were tested using a standard climbing assay (mean±SEM, n = 100 flies per genotype, asterisks, one-way ANOVA with Dunnett’s multiple comparison test). (g) dNK expression suppresses flight muscle defects observed in pink1 mutants. dNK expression rescues mitochondrial defects in pink1 mutants (my, myofibrils; m, mitochondria; yellow outlines, mitochondria). See also Supplementary Figs 3 and 9.

Back to article page